NCIt definition : A preparation of autologous, personalized, immunogenic and tumor neoantigen-specific
T-lymphocytes, with potential immunostimulating and antineoplastic activities. Tumor-specific
neoantigen targets of autologous CD4 and/or CD8 T-cells are identified and T-cells
that target immunogenic and stimulatory neoantigens are expanded ex vivo. Upon administration,
the autologous neoantigen-specific T-lymphocytes GEN-011 recognize and bind to tumor
cells expressing the targeted neoantigens, resulting in a cytotoxic T-lymphocyte (CTL)-mediated
immune response against the patient's tumor cells.;